Kevin A. Lobo's Insider Trades & SAST Disclosures
Kevin A. Lobo's most recent trade in Stryker Corp. was a trade of 23,321 Common Stock done at an average price of $374.2 . Disclosure was reported to the exchange on March 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kevin A. Lobo.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 374.22 per share. | 21 Mar 2025 | 23,321 | 122,304 (0%) | 0% | 374.2 | 8,727,185 | Common Stock |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2025 | 1,085 | 0 | - | - | Dividend Equivalents | |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2025 | 1,085 | 145,625 (0%) | 0% | 0 | Common Stock | |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 44,507 | 144,540 (0%) | 0% | 0 | Common Stock | |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 48,936 | 48,936 | - | - | Employee Stock Option granted 02/05/2025 (right to buy) | |
| Parker-Hannifin Corp. | Kevin A. Lobo | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Nov 2024 | 3,465 | 7,612 (0%) | 0% | 0 | Common Stock | |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2024 | 156,890 | 0 | - | - | Employee Stock Option granted 2/11/2015 (right to buy) | |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 93.06 per share. | 07 Nov 2024 | 156,890 | 256,917 (0%) | 0% | 93.1 | 14,600,183 | Common Stock |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 369.02 per share. | 07 Nov 2024 | 99,577 | 157,340 (0%) | 0% | 369.0 | 36,745,905 | Common Stock |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 368.58 per share. | 07 Nov 2024 | 23,178 | 115,893 (0%) | 0% | 368.6 | 8,542,947 | Common Stock |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 367.95 per share. | 07 Nov 2024 | 18,269 | 139,071 (0%) | 0% | 368.0 | 6,722,079 | Common Stock |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 369.75 per share. | 07 Nov 2024 | 15,866 | 100,027 (0%) | 0% | 369.8 | 5,866,454 | Common Stock |
| Parker-Hannifin Corp. | Kevin A. Lobo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2024 | 299 | 11,077 (0%) | 0% | 0 | Restricted Stock Units | |
| Parker-Hannifin Corp. | Kevin A. Lobo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2024 | 299 | 11,077 (0%) | 0% | 0 | Restricted Stock Units | |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 353.19 per share. | 21 Mar 2024 | 19,785 | 99,934 (0%) | 0% | 353.2 | 6,987,864 | Common Stock |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2024 | 905 | 119,719 (0%) | 0% | 0 | Common Stock | |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2024 | 905 | 0 | - | - | Dividend Equivalents | |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 37,773 | 118,814 (0%) | 0% | 0 | Common Stock | |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 67,695 | 67,695 | - | - | Employee Stock Option granted 02/07/2024 (right to buy) | |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 81.14 per share. | 17 Nov 2023 | 160,215 | 241,249 (0%) | 0% | 81.1 | 12,999,845 | Common Stock |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2023 | 160,215 | 0 | - | - | Employee Stock Option granted 02/12/2014 (right to buy) | |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 291.55 per share. | 17 Nov 2023 | 103,732 | 137,517 (0%) | 0% | 291.6 | 30,243,065 | Common Stock |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 287.42 per share. | 17 Nov 2023 | 32,857 | 104,660 (0%) | 0% | 287.4 | 9,443,713 | Common Stock |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 288.26 per share. | 17 Nov 2023 | 15,092 | 89,568 (0%) | 0% | 288.3 | 4,350,408 | Common Stock |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 289.12 per share. | 17 Nov 2023 | 8,060 | 81,508 (0%) | 0% | 289.1 | 2,330,285 | Common Stock |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 289.89 per share. | 17 Nov 2023 | 474 | 81,034 (0%) | 0% | 289.9 | 137,406 | Common Stock |
| Parker-Hannifin Corp. | Kevin A. Lobo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2023 | 453 | 10,773 (0%) | 0% | 0 | Restricted Stock Units | |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Jun 2023 | 8,904 | 80,959 (0%) | 0% | 0 | Common Stock | |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 276.83 per share. | 21 Mar 2023 | 9,425 | 89,828 (0%) | 0% | 276.8 | 2,609,123 | Common Stock |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2023 | 504 | 99,253 (0%) | 0% | 0 | Common Stock | |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2023 | 504 | 0 | - | - | Dividend Equivalents | |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2023 | 17,971 | 98,749 (0%) | 0% | 0 | Common Stock | |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 100,665 | 100,665 | - | - | Employee Stock Option granted 02/09/2023 (right to buy) | |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2022 | 187,470 | 0 | - | - | Employee Stock Option granted 02/13/2013 (right to buy) | |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.01 per share. | 02 Dec 2022 | 187,470 | 268,240 (0%) | 0% | 64.0 | 11,999,955 | Common Stock |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 240.77 per share. | 02 Dec 2022 | 120,238 | 148,002 (0%) | 0% | 240.8 | 28,949,703 | Common Stock |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 239.43 per share. | 02 Dec 2022 | 43,809 | 104,193 (0%) | 0% | 239.4 | 10,489,031 | Common Stock |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 240.16 per share. | 02 Dec 2022 | 23,423 | 80,770 (0%) | 0% | 240.2 | 5,625,268 | Common Stock |
| Parker-Hannifin Corp. | Kevin A. Lobo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Oct 2022 | 653 | 10,310 (0%) | 0% | 0 | Restricted Stock Units | |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 33,925 | 0 | - | - | 2019 Performance Stock Units | |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 33,925 | 97,976 (0%) | 0% | 0 | Common Stock | |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 33,043 | 33,043 | - | - | 2019 Performance Stock Units | |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 267.34 per share. | 04 Mar 2022 | 17,329 | 80,647 (0%) | 0% | 267.3 | 4,632,735 | Common Stock |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 128,220 | 128,220 | - | - | Employee Stock Option granted 02/02/2022 (right to buy) | |
| Parker-Hannifin Corp. | Kevin A. Lobo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2021 | 556 | 9,648 | - | 0 | Restricted Stock Units | |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.66 per share. | 03 May 2021 | 107,795 | 171,773 (0%) | 0% | 55.7 | 5,999,870 | Common Stock |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2021 | 107,795 | 0 | - | - | Employee Stock Option granted 10/01/2012 (right to buy) | |
| Stryker Corp. | Kevin A. Lobo | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 255.79 per share. | 03 May 2021 | 107,795 | 63,978 (0%) | 0% | 255.8 | 27,573,142 | Common Stock |
| Stryker Corp. | Kevin A. Lobo | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2021 | 26,674 | 77,574 (0%) | 0% | 0 | Common Stock | |
| Stryker Corp. | Kevin A. Lobo | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Mar 2021 | 19,514 | 50,900 (0%) | 0% | 0 | Common Stock | |
| Stryker Corp. | Kevin A. Lobo | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 230.00 per share. | 21 Mar 2021 | 13,646 | 63,928 (0%) | 0% | 230 | 3,138,580 | Common Stock |
| Stryker Corp. | Kevin A. Lobo | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 127,590 | 127,590 | - | - | Employee Stock Option granted 02/03/2021 (right to buy) | |
| Stryker Corp. | Kevin A. Lobo | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.60 per share. | 07 Dec 2020 | 27,985 | 98,376 (0%) | 0% | 53.6 | 1,499,996 | Common Stock |
| Stryker Corp. | Kevin A. Lobo | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2020 | 27,985 | 0 | - | - | Employee Stock Option granted 02/21/2012 (right to buy) | |
| Stryker Corp. | Kevin A. Lobo | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 239.59 per share. | 07 Dec 2020 | 17,288 | 81,088 (0%) | 0% | 239.6 | 4,142,032 | Common Stock |
| Stryker Corp. | Kevin A. Lobo | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 236.28 per share. | 07 Dec 2020 | 10,697 | 70,391 (0%) | 0% | 236.3 | 2,527,534 | Common Stock |
| Parker-Hannifin Corp. | Kevin A. Lobo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2020 | 729 | 9,083 (0%) | 0% | 0 | Common Stock | |
| Stryker Corp. | Kevin A. Lobo | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 190.80 per share. | 30 Jul 2020 | 25,855 | 70,349 (0%) | 0% | 190.8 | 4,933,046 | Common Stock |
| Stryker Corp. | Kevin A. Lobo | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2020 | 25,855 | 0 | - | - | Employee Stock Option granted 04/26/2011 (right to buy) | |
| Stryker Corp. | Kevin A. Lobo | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.02 per share. | 30 Jul 2020 | 25,855 | 96,204 (0%) | 0% | 58.0 | 1,500,107 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges